SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001576280-23-000186
Filing Date
2023-11-06
Accepted
2023-11-06 16:10:48
Documents
14
Period of Report
2023-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gh-20231106.htm   iXBRL 8-K 30308
2 EX-99.1 gh-09302023xexhibit991.htm EX-99.1 258314
6 GRAPHIC guardantlogoa01.gif GRAPHIC 17260
  Complete submission text file 0001576280-23-000186.txt   457638

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20231106.xsd EX-101.SCH 2001
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20231106_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20231106_pre.xml EX-101.PRE 12605
8 EXTRACTED XBRL INSTANCE DOCUMENT gh-20231106_htm.xml XML 2798
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 231380075
SIC: 8071 Services-Medical Laboratories